(Q38319580)

2 September 2017

1 reference

title

Environmental (nongenetic) factors in gynecological cancers: update and future perspectives (English)

1 reference

2 September 2017

1

Penelope M Webb

1 reference

PubMed ID

25591840

2 September 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

2 September 2017

1 reference

2 September 2017

11

1 reference

2 September 2017

2

1 reference

2 September 2017

295-307

1 reference

Role of genetic polymorphisms and ovarian cancer susceptibility

2 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Gynecological conditions and the risk of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Type I and II endometrial cancers: have they different risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Twinning and the Incidence of Breast and Gynecological Cancers (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Multiple births and risk of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological stu

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Hormonal contraception and risk of endometrial cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Ovarian cancer and hormone replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Menopausal hormone therapy and risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Body size in relation to cancer of the uterine corpus in 1 million Norwegian women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Weight change and risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Dietary intake and ovarian cancer risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Green and black tea in relation to gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Tea consumption and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Cigarette smoking and the risk of endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Perineal powder use and risk of endometrial cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Use of talcum powder and endometrial cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

10. Cancers attributable to exposure to hormones in the UK in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Nutrition and physical activity guidelines for cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Obesity and ovarian cancer survival: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Dietary influences on survival after ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Green tea consumption enhances survival of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Ovarian carcinoma pathology and genetics: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

Breastfeeding and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.142

21 January 2018

Identifiers

DOI

10.2217/FON.14.142

1 reference

2 September 2017

1 reference